MDXG
MiMedx Group, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.57
+3.16%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.62x
- Debt / assets
- 0.01x
- Debt / EBITDA
- 0.06x
- Net debt / EBITDA
- -5.67x
Liquidity & coverage
- Current ratio
- 5.33x
- Quick ratio
- 4.79x
- Cash ratio
- 3.53x
- Interest coverage
- 5.50x
- EBITDA / interest
- 14.88x
- Working capital
- $166.9M
Cash & dividend
- FCF / debt
- 27.05x
- Cash flow / debt
- 30.77x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026